Andrea Fava, MD

Postdoctoral Fellow

Andrea Fava, MD

View full profile

Related Videos

Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better than Proteinuria Video

Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better than Proteinuria

Rheumatologist Andrea Fava has identified accurate, noninvasive biomarkers found in urine that can be used to better diagnose and guide treatment for lupus nephritis.

Andrea Fava, MD - Urine Proteomics and Single Cell Transcriptomics Identify IL-16 as a Biomarker for Lupus Nephritis Video

Andrea Fava, MD - Urine Proteomics and Single Cell Transcriptomics Identify IL-16 as a Biomarker for Lupus Nephritis

Andrea Fava discusses the use of urine samples to detect a patient’s kidney disease progression.

Renal Single Cell Genomics Links Type II Interferon and Lupus Nephritis in African-Americans Video

Renal Single Cell Genomics Links Type II Interferon and Lupus Nephritis in African-Americans

Andrea Fava says we are currently neglecting the development of specific treatments that could target the particular cells involved in driving lupus in African American patients.

Part II - Toward a Liquid Biopsy for Lupus Nephritis: Urine Proteomic Analysis of SLE Identifies Inflammatory and Macrophage Signatures Video

Part II - Toward a Liquid Biopsy for Lupus Nephritis: Urine Proteomic Analysis of SLE Identifies Inflammatory and Macrophage Signatures

In their study, Andrea Fava and colleagues used an assay that allows them to measure a thousand proteins in urine — urine proteomics.

Toward a Liquid Biopsy for Lupus Nephritis: Urine Proteomic Analysis of SLE Identifies Inflammatory and Macrophage Signatures Video

Toward a Liquid Biopsy for Lupus Nephritis: Urine Proteomic Analysis of SLE Identifies Inflammatory and Macrophage Signatures

Lupus nephritis is one of the worst manifestations of lupus.